The Impact of Exacerbation Frequency on Clinical and Economic Outcomes in Swedish COPD Patients: The ARCTIC Study

被引:9
|
作者
Larsson, Kjell [1 ]
Janson, Christer [2 ]
Lisspers, Karin [3 ]
Stallberg, Bjorn [3 ]
Johansson, Gunnar [3 ]
Gutzwiller, Florian S. [4 ]
Mezzi, Karen [4 ]
Bjerregaard, Bine Kjoeller [5 ]
Jorgensen, Leif [5 ]
机构
[1] Karolinska Inst, Natl Inst Environm Med, Integrat Toxicol, SE-17177 Stockholm, Sweden
[2] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden
[3] Uppsala Univ, Dept Publ Hlth & Caring Sci, Family Med & Prevent Med, Uppsala, Sweden
[4] Novartis Pharma AG, Global Patient Access, Basel, Switzerland
[5] IQVIA Solut, Real World Evidence Solut, Copenhagen, Denmark
关键词
chronic obstructive pulmonary disease; exacerbations; mortality; lung function; healthcare cost; Sweden; OBSTRUCTIVE PULMONARY-DISEASE; MANAGEMENT; DIAGNOSIS; MORTALITY; OVERLAP; DECLINE;
D O I
10.2147/COPD.S297943
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose: The aim of this study was to assess the association between exacerbation frequency and clinical and economic outcomes in patients with COPD. Patients and Methods: Electronic medical record data linked to National Health Registries were collected from COPD patients at 52 Swedish primary care centers (2000-2014). The outcomes analyzed were exacerbation rate, mortality, COPD treatments, lung function and healthcare costs during the follow-up period. Based on the exacerbation rate two years before index date, the patients were initially classified into three groups, either 0, 1 or >= 2 exacerbations per year. After the index date, the classification into exacerbation groups was updated each year based on the exacerbation rate during the last year of follow-up. A sensitivity analysis was conducted excluding patients with asthma diagnosis from the analysis. Results: In total 18,586 COPD patients were analyzed. A majority of the patients (60-70%) who either have had no exacerbation or frequent exacerbations (>= 2/year) during the preindex period remained in their group (ie, with 0 or >= 2 annual exacerbations) during up to 11 years of follow-up. Compared with having no exacerbation, mortality was higher in patients having 1 (HR; 2.06 [1.93-2.201) and >= 2 (4.58 [4.33-4.841) exacerbations at any time during the follow-up. Lung function decline was more rapid in patients with frequent exacerbations and there was an almost linear relationship between exacerbations frequency and mortality. Total healthcare costs were higher in the frequent exacerbation group (>= 2/year) than in patients with no or one exacerbation annually (p<0.0001 for both). The results did not differ from the main analysis after exclusion of patients with a concurrent asthma diagnosis. Conclusion: In addition to faster lung function decline and increased mortality, frequent exacerbations in COPD patients imply a significant economic burden.
引用
收藏
页码:701 / 713
页数:13
相关论文
共 50 条
  • [21] Comparison of clinical characteristics and outcomes of patients with COPD exacerbation with or without venous thromboembolism
    Akgun, Metin
    Meral, Mehmet
    Onbas, Omer
    Araz, Omer
    Koplay, Mustafa
    Aslan, Sahin
    Mirici, Arzu
    RESPIRATION, 2006, 73 (04) : 428 - 433
  • [22] CONCURRENT COPD/PNEUMONIA: INCIDENCE AND CLINICAL OUTCOMES AMONG PATIENTS ADMITTED WITH EXACERBATION
    Ahmad, N.
    George, S.
    Davis, E.
    Srinivasan, K. S.
    Moudgil, H.
    THORAX, 2009, 64 : A117 - A117
  • [23] Extent And Impact Of Late Versus Early COPD Diagnosis In Women In The Swedish Arctic Study
    Lisspers, K.
    Larsson, K.
    Janson, C.
    Stallberg, B.
    Gutzwiller, F. S.
    Mezzi, K.
    Uhde, M.
    Jorgensen, L.
    Johansson, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [24] Extent and impact of late vs early stage COPD diagnosis in the Swedish ARCTIC study
    Larsson, Kjell Ake
    Janson, Christer
    Stallberg, Bjorn
    Lisspers, Karin
    Olsson, Petter
    Kostikas, Konstantinos
    Uhde, Milica
    Jorgensen, Leif
    Sobocki, Patrik
    Johansson, Gunnar
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [25] CLINICAL FEATURES ACCORDING TO FREQUENCY OF ACUTE EXACERBATION IN COPD
    Lee, S. J.
    RESPIROLOGY, 2011, 16 : 94 - 94
  • [26] Clinical Features according to the Frequency of Acute Exacerbation in COPD
    Lee, Seung Jun
    Lee, Seung Hun
    Kim, Yu Eun
    Cho, Yu Ji
    Jeong, Yi Yeong
    Kim, Ho Cheol
    Kim, Jin Hyun
    You, Jin Jong
    Yoon, Chul-Ho
    Lee, Jong Deog
    Hwang, Young Sil
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2012, 72 (04) : 367 - 373
  • [27] CLINICAL FEATURES ACCORDING TO FREQUENCY OF ACUTE EXACERBATION IN COPD
    Lee, S. J.
    Kim, Y. E.
    Cho, Y. J.
    Kim, H. C.
    Lee, J. D.
    Hwang, Y. S.
    RESPIROLOGY, 2011, 16 : 97 - 97
  • [28] Impact of Comorbidities in Clinical Outcomes in Patients Admitted for Exacerbation of Bronchiectasis
    Urrutia-Royo, Blanca
    Garcia-Olive, Ignasi
    Compte, Marina
    Folgado, Carlos
    Rosell, Antoni
    Capa, Jorge Abad
    ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (11): : 762 - 764
  • [29] THE ECONOMIC IMPACT OF OPTIMIZED POST-HOSPITALIZATION MANAGEMENT FOR AN EXACERBATION IN COPD PATIENTS IN CHINA
    Salem, A.
    Ramos, M.
    Hu, H.
    Zhong, H.
    Lamotte, M.
    VALUE IN HEALTH, 2018, 21 : S409 - S409
  • [30] ECONOMIC IMPACT OF AVOIDABLE DRUG WASTAGE IN PATIENTS ADMITTED TO THE HOSPITAL FOR AN ACUTE COPD EXACERBATION
    Bollu, V
    Clark, R. S.
    Carlton, R.
    Meyer, K. L.
    VALUE IN HEALTH, 2015, 18 (03) : A172 - A172